• Editor’s Pick
  • Investing
  • Economy
  • Stock
  • Politics
Income Researchers
Investing

Acceleration of RAD204 Phase 1 dose escalation trial

by May 12, 2025
May 12, 2025

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com
previous post
Excellent Gold Intersections Verified at Kiimala Project
next post
Multiple New Multi-Commodity Targets

Related Posts

Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical...

May 12, 2025

Finlay Minerals Appoints an Executive Chairman, President &...

May 12, 2025

Nuvau Minerals Completes High Resolution Drone MAG Survey

May 12, 2025

Falco Files Requested Documentation for the Horne 5 Project’s...

May 12, 2025

Triumph Gold Discovers a New Silver and Gold...

May 12, 2025

Multiple New Multi-Commodity Targets

May 12, 2025

Excellent Gold Intersections Verified at Kiimala Project

May 11, 2025

Tech 5: OpenAI Restructures, Apple Pursues AI Search,...

May 11, 2025

Crypto Market Recap: Bitcoin Breaks US$100,000, Coinbase Makes...

May 11, 2025

Top 5 Canadian Mining Stocks This Week: Group...

May 11, 2025

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • Trump says China agrees to ‘fully’ open country’s markets to US businesses

      May 12, 2025
    • Trump defends Qatar jumbo jet offer as troubled Boeing fails to deliver new Air Force One fleet

      May 12, 2025
    • President Trump takes on ‘Big Pharma’ by signing executive order to lower drug prices

      May 12, 2025
    • Senate parliamentarian: Who is the unelected official getting say on Trump’s ‘big, beautiful bill?’

      May 12, 2025
    • Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee

      May 12, 2025

    Archives

    • May 2025 (281)
    • April 2025 (531)
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 incomeresearchers.com | All Rights Reserved

    Income Researchers
    • Editor’s Pick
    • Investing
    • Economy
    • Stock
    • Politics

    Read alsox

    Trump Takes Aim at China with Deep-Sea Mining...

    April 29, 2025

    Lahontan Announces Upsize to Private Placement of Units

    April 22, 2025

    xU3O8 (uranium.io): Pioneering Physical Uranium Ownership Powered by...

    May 1, 2025